In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone - sprookjes - yvandenbroek - TriplyDB

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

http://www.wikidata.org/entity/Q28343293

about

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.Influence of First-Line Antibiotics on the Antibacterial Activities of Acetone Stem Bark Extract of Acacia mearnsii De Wild. against Drug-Resistant Bacterial Isolates.Comparative antianaerobic activity of BMS 284756 Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinolone.Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae.In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756.Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.Antipneumococcal activity of BMS 284756 compared to those of six other agents.Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate.In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms.Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.Synthesis of difluoromethyl ethers with difluoromethyltriflate.Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA).

P2860

Q28344944-9B1729EB-2B29-4160-9FF8-C18AF2CCE839 Q33836590-E72DEB04-FFD3-4ADD-A5E6-00E6D408078D Q33914695-578FE445-6BFE-4E7C-BC97-0AAE4F40E1E2 Q33981466-4D95E679-EDF5-4257-AF3A-500BB551DD38 Q33982083-93E340D8-54F3-42F1-93E4-E3745FB538E0 Q33983338-2A8CD9C1-7340-4EB7-9575-F009859887BE Q34104362-8BF98FAC-3BC8-482C-A8A3-441A522F1903 Q34104548-110ED618-5370-4F99-BCDA-95B21ECB27F7 Q34108423-90E39588-1A74-44EF-8756-40BA963434D1 Q34142238-76BF9F76-90D8-457B-98D3-54E8ACE017EA Q34719869-6A75908F-8A3B-4F7B-AAB3-138C08D42064 Q35102747-03EE9507-7730-4265-BE12-F7E7CF9CEDCE Q35127828-4413CE10-FA53-436D-A572-FC0A89C83BF4 Q35636510-9D9ACA35-CAE2-473E-A1AF-5B52280B8103 Q35644095-B0F599E2-F2BA-4E60-AD89-8B2D8029CAA5 Q37869167-BCC9BFEA-24B4-4C36-8C8F-1DF3D731B93E Q39476076-FD6A1003-66EF-41E0-9617-49F1852A73D6 Q39478563-9045262B-6F87-41CD-9BF3-9536CA689C8C Q39479356-59725711-123B-4846-8C01-D6493BE84931 Q39650891-9194FE92-1C71-4F8F-959D-52AA82E2A226 Q39651041-FDA0DBC7-4104-4793-BA26-D9A2822F0E3A Q39652821-EBE56A93-28E8-4C90-BE6D-6640C7F6EA84 Q39652932-C93EBFBE-E173-4EB8-BBCC-0AEB2ED6D424 Q39731884-41EF8E7F-6455-494C-8F60-C668484C3DAF Q39743439-94730867-AA4B-4C9C-9EDE-4BB3577B7B39 Q40130484-3B1F8FA6-9686-402E-95F4-E0484DBD9B5C Q40130516-322D0864-58A8-4456-8DC9-25B5C4CD07F9 Q40130597-5C2CD8A4-204C-4CDF-9300-12E57803F46A Q42747636-5C4800F0-4F26-4023-930E-AF137E514B04 Q42782033-2E47744F-0432-4A8D-AE50-8C97B4361A50 Q42905296-4C61DA4B-BA8E-4E4D-A0F7-4FC099502949 Q42922807-6E5D0979-A45E-483A-801C-15A5C08D3B53

P2860

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

http://www.wikidata.org/entity/Q28343293

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@ast

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@en

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@nl

type

label

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@ast

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@en

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@nl

prefLabel

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@ast

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@en

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@nl

P1433

Q28343293-47FA9B87-813F-4A5C-895D-A7EA606D863B

P1476

Q28343293-9E04501E-EFC9-44B0-A28D-B6CA86281007

P2093

Q28343293-33E78346-9E11-47CE-9798-AE1BF06464F9

Q28343293-49FC9D94-B4D0-41C0-8F81-4EA524E11C9F

Q28343293-4B4E5859-D88D-46DB-8646-278CC9E3C4F0

Q28343293-6DEF75BB-60E1-4047-8EEB-E479516AFDA7

Q28343293-78ABF8B8-FDF8-451B-891E-4624EE3C5FE5

Q28343293-95336F1F-6DE4-49CC-896E-2CA49D0650E3

Q28343293-C9CC8843-9BE7-4B7A-9A7A-7595660CC7D7

Q28343293-CC8B236C-634A-4FBB-9DA6-EE6CB21EE49E

Q28343293-DD5AEC4E-FD0C-48D3-81BF-38A6B1D411AB

P2860

Q28343293-028FEE2D-0E40-40FF-A69D-95492047CA6C

Q28343293-076D076E-FA67-4210-B8ED-1B1554A758C7

Q28343293-086B7084-99BE-47C9-8368-0CF89F073D48

Q28343293-3FB7671E-0DD7-4F05-B04E-BEE1F57C1536

Q28343293-50648D9D-0D3B-43AC-8330-BFBF9338CF91

Q28343293-5412D6CE-27AA-4AB9-A710-937FDC8993F9

Q28343293-7CEE0A03-FBB6-494A-9621-86A2A4D5FC38

Q28343293-80A30CAD-FC00-4A66-BF06-82D829DF5DA1

Q28343293-89439D36-50C8-44D2-81F5-6E422D90F7D9

Q28343293-9ACAB53D-BFA8-46D7-86C6-C6E60D3766C1

P304

Q28343293-E179B026-0A2C-4120-803A-F3C173CA2217

P31

Q28343293-7405CE84-DC10-4C3B-B92E-747C2E22F682

P356

Q28343293-72271D31-56CE-44E6-AC6C-9755F46BB6AC

P407

Q28343293-DD5A68AC-34B9-41FD-9447-B33C7E047522

P433

Q28343293-27E28452-4027-47FE-9C95-9DA785D77901

P478

Q28343293-FDD478AE-9D01-4C15-BD26-BC2F3196618D

P577

Q28343293-902AD1CE-EE01-4DA0-B56E-229BAD1F0A43

P698

Q28343293-E8BDD7C8-00E7-4B5E-AB67-82ED0EB4D1F2

P921

Q28343293-9F84791D-3B65-4522-ADF1-F534644AB4C8

P932

Q28343293-54C77D48-7754-4488-9BB9-A5C28A13D71F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

@en

P2093

H Araki

http://www.w3.org/2001/XMLSchema#string

H Narita

http://www.w3.org/2001/XMLSchema#string

J Mitsuyama

http://www.w3.org/2001/XMLSchema#string

M Takahata

http://www.w3.org/2001/XMLSchema#string

M Yonezawa

http://www.w3.org/2001/XMLSchema#string

S Minami

http://www.w3.org/2001/XMLSchema#string

Y Todo

http://www.w3.org/2001/XMLSchema#string

Y Watanabe

http://www.w3.org/2001/XMLSchema#string

Y Yamashiro

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.

Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia

In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.

In vitro activity of the new fluoroquinolone CP-99,219.

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.

The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents.

Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).

Glycopeptides in the treatment of staphylococcal infections.

P304

1077-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.5.1077

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10223917

http://www.w3.org/2001/XMLSchema#string

P921

P932

89114

http://www.w3.org/2001/XMLSchema#string